Collegium Pharmaceutical (COLL) Work In Process (2016 - 2025)

Collegium Pharmaceutical has reported Work In Process for 10 years, with the latest figure at $11.6 million in Q3 2025.

• On a quarterly basis, Work In Process fell 33.12% year-over-year to $11.6 million in Q3 2025; TTM through Sep 2025 was $11.6 million, a 33.12% decrease from a year earlier, with the FY2024 full-year figure at $13.2 million, up 95.3% from the prior year.
• Work In Process was $11.6 million for Q3 2025 at Collegium Pharmaceutical, down from $12.1 million in the prior quarter.
• The five-year high for Work In Process was $46.4 million in Q2 2022, with the low at $802000.0 in Q1 2021.
• Average Work In Process over 5 years is $14.1 million, with a median of $11.6 million recorded in 2025.
• The sharpest annual moves came in 2022 and 2023: Work In Process jumped 4252.49% in 2022, then plunged 83.92% in 2023.
• Over 5 years, Work In Process stood at $1.0 million in 2021, then jumped by 2350.05% to $24.7 million in 2022, then sank by 72.68% to $6.7 million in 2023, then jumped by 95.3% to $13.2 million in 2024, then fell by 11.65% to $11.6 million in 2025.
• The last three Work In Process figures came in at $11.6 million (Q3 2025), $12.1 million (Q2 2025), and $11.6 million (Q1 2025), per Business Quant data.